Comparing two moisturizers for mild to moderate eczema
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests if two different moisturizing balms work equally well for treating mild to moderate eczema (atopic dermatitis) in children and adults. It may help find a more affordable or better-tolerated option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 6 months and 70 years old.
- You must have mild to moderate eczema (scored under 40 on the SCORAD scale).
- You must be able to start using the balm within 72 hours of your doctor's checkup.
- You must be part of the French national health insurance and speak French.
- You must sign a consent form.
- You must not have severe eczema that needs stronger medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two moisturizers for people with eczema (moderate rash) and healthy volunteers. It looks at how well they work and how the skin tolerates them after using a steroid cream.
This trial tests if crisaborole ointment works better and is safer than tacrolimus ointment for mild to moderate atopic dermatitis (eczema). It may help you find a new treatment option.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
This trial tests an experimental drug called EC-18 (a pill) for people with moderate to severe eczema that hasn't been controlled well with creams. It aims to see if different doses of the drug can safely reduce itching and skin rash.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.